These Were The Five Best- And Worst-Performing Mega-Cap Stocks In July 2022

Published on

After a dismal performance in the first six months of 2022, July offered some respite for stock market investors. In fact, July has been the best month for the S&P 500 since November 2020. The index gained more than 9% last month, and all of the top mega-cap stocks offered decent returns to investors. Let’s take a look at the five best- and worst-performing mega-cap stocks in July 2022.

Get The Full Series in PDF

Get the entire 10-part series on Charlie Munger in PDF. Save it to your desktop, read it on your tablet, or email to your colleagues.

Q2 2022 hedge fund letters, conferences and more

 

The Five Best-Performing Mega-Cap Stocks In July 2022

We have used the July return data for mega-cap stocks from finviz.com to rank the five best- and worst-performing mega-cap stocks in July 2022. Let’s start with the five best-performing mega-cap stocks in July 2022:

  1. Danaher (15%)

Founded in 1984 and headquartered in Washington, D.C., Danaher is a medical company that develops professional, medical, industrial, and commercial products and services. Danaher Corporation (NYSE:DHR) shares have lost almost 12% year to date and are down more than 2% in the last year. As of the time of this writing, the company's shares are trading at more than $290. They have a 52-week range of $233.71 to $333.96. Danaher reported more than $29 billion in revenue for 2021 and over $22 billion in 2020.

  1. Apple (17%)

Founded in 1976 and headquartered in Cupertino, California, this company develops and sells smartphones, tablets, wearables, computers, and related services and software. Apple Inc (NASDAQ:AAPL) shares have lost more than 8% year to date but are up by almost 12% in the last year. As of the time of this writing, Apple shares are trading at above $162, and their 52-week range is $129.04 to $182.94. Apple reported more than $360 billion in revenue for 2021 and over $270 billion in 2020.

  1. NVIDIA (17%)

Founded in 1993 and headquartered in Santa Clara, California, NVIDIA is a computing platform company that develops graphics-processor technologies for workstations, desktop computers, and mobile devices. NVIDIA Corporation (NASDAQ:NVDA) shares have lost almost 36% year to date and are down by over 7% in the last year. As of the time of this writing, the chipmaker's shares are trading at above $184 with a 52-week range of $140.55 to $346.47. NVIDIA reported more than $26 billion in revenue for 2021 and over $16 billion in 2020.

  1. Amazon.com (24%)

Founded in 1994 and headquartered in Seattle, Washington, Amazon is an e-commerce company that also serves developers and enterprises through Amazon Web Services. Amazon.com, Inc. (NASDAQ:AMZN) shares have lost more than 18% year to date and are down by almost 18% in the last year. As of the time of this writing, the company's shares are trading at above $136, and their 52-week range is $101.26 to $188.11. Amazon reported more than $460 billion in revenue for 2021 and over $380 billion in 2020.

  1. Tesla (30%)

Founded in 2003 and headquartered in Austin, Texas, this company develops and sells fully electric vehicles and energy generation and storage systems. Tesla Inc (NASDAQ:TSLA) shares have lost almost 13% year to date but have gained almost 30% in the last year. As of the time of this writing, the company's shares are trading at above $923 with a 52-week range of $620.57 to $1,243.49. Tesla reported more than $53 billion in revenue for 2021 and over $31 billion in 2020.

The Five Worst-Performing Mega-Cap Stocks In July 2022

Here are the five worst-performing mega-cap stocks in July 2022:

  1. Johnson & Johnson (-1%)

Founded in 1886 and headquartered in Brunswick, New Jersey, this company develops and sells healthcare products. Johnson & Johnson (NYSE:JNJ) shares have gained almost 2% year to date and are up by almost 1% in the last year. As of the time of this writing, the company's shares are trading at above $173 with a 52-week range of $155.72 to $186.69. Johnson & Johnson reported more than $90 billion in revenue for 2021 and over $80 billion in 2020.

  1. Procter & Gamble (-2%)

Founded in 1837 and headquartered in Cincinnati, Ohio, Procter & Gamble is a consumer goods company that offers products and services for various rooms, including kitchens, laundry rooms, bathrooms and more. Procter & Gamble Co (NYSE:PG) shares have lost almost 14% year to date and are down by almost 1% in the last year. As of the time of this writing, the company's shares are trading at above $140 with a 52-week range of $129.50 to $165.35. Procter & Gamble reported more than $76 billion in revenue for 2021 and over $70 billion in 2020.

  1. Meta Platforms (-3%)

Founded in 2004 and headquartered in Menlo Park, California, this company develops and operates social media apps. Meta Platforms Inc (NASDAQ:META) shares have lost more than 52% year to date and are down by almost 55% in the last year. As of the time of this writing, the company's shares are trading at above $159 with a 52-week range of $154.25 to $384.33. Meta Platforms reported more than $110 billion in revenue for 2021 and over $80 billion in 2020.

  1. Merck & Co. (-3%)

Founded in 1891 and headquartered in Kenilworth, New Jersey, this company offers health solutions through its prescription medicines, animal health products, vaccines, biologic therapies and consumer care product lines. Merck & Co., Inc. (NYSE:MRK) shares have gained almost 16% year to date and are up by over 16% in the last year. As of the time of this writing, the company's shares are trading at above $88 with a 52-week range of $70.89 to $95.72. Merck & Co. reported more than $48 billion in revenue for 2021 and over $41 billion in 2020.

  1. AbbVie (-7%)

Founded in 2011 and headquartered in North Chicago, Illinois, AbbVie is a biopharmaceutical company that focuses on developing and selling pharmaceutical products that treat conditions such as chronic autoimmune diseases. AbbVie Inc (NYSE:ABBV) shares have gained more than 4% year to date and are up by over 22% in the last year. As of the time of this writing, the company's shares are trading at above $140 with a 52-week range of $105.56 to $175.91. AbbVie reported more than $56 billion in revenue for 2021 and over $45 billion in 2020.